Hudock Inc’s Takeda Pharmaceutical TAK Stock Holding History

Hudock Inc’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-767	Closed	-$9K	–	665
2022 Q3	$9K	Hold	767	–	–	﹤0.01%	541
2022 Q2	$10K	Hold	767	–	–	﹤0.01%	528
2022 Q1	$10K	Sell	767 -521	-40%	-$7.65K	﹤0.01%	546
2021 Q4	$17K	Hold	1,288	–	–	﹤0.01%	472
2021 Q3	$21K	Hold	1,288	–	–	0.01%	446
2021 Q2	$21K	Hold	1,288	–	–	0.01%	439
2021 Q1	$23K	Hold	1,288	–	–	0.01%	426
2020 Q4	$23K	Hold	1,288	–	–	0.01%	411
2020 Q3	$22K	Hold	1,288	–	–	0.01%	370
2020 Q2	$23K	Hold	1,288	–	–	0.01%	353
2020 Q1	$19K	Hold	1,288	–	–	0.01%	332
2019 Q4	$25K	Hold	1,288	–	–	0.01%	318
2019 Q3	$22K	Hold	1,288	–	–	0.01%	334
2019 Q2	$22K	Hold	1,288	–	–	0.01%	333
2019 Q1	$26K	Buy	+1,288	New	+$25.9K	0.01%	306

Other funds holding TAK

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hudock Inc's TAK Position: Q4 2022 in Review

Hudock Inc sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 767 shares — an estimated $9K sold.

Hudock Inc first reported a position in TAK in Q1 2019 and held it in 15 quarters. The position peaked at $26K in Q1 2019. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

Hudock Inc reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
Hudock Inc sold 767 Takeda Pharmaceutical shares in Q4 2022, an estimated $9K.
Hudock Inc first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 15 quarters.
Hudock Inc's Takeda Pharmaceutical position peaked at $26K in Q1 2019.
281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.